Qualitative USE
|
Non-invasive
No contrast medium
Safe
Same probe and US machine of B-mode evaluation
Defined in some guidelines
Not overly time-consuming
Good intra-observed agreement
|
Subjective evaluation (low inter-observed agreement)
Non-univocal classification (4- or 5-point scale scoring systems)
Soft carcinoma evaluation (thyroid follicular carcinoma)
Undefined thyroiditis influence
Calcific nodule may be wrongly assessed
Cystic nodule may be wrongly assessed
|
Semi-Quantitative USE
|
Non-invasive
No contrast medium
Safe
Same probe and US machine of B-mode evaluation
Defined in some guidelines
Not overly time-consuming
Good intra-observed agreement
Good inter-observed agreement
|
Univocal cut-off missing
Soft carcinoma evaluation (thyroid follicular carcinoma)
Undefined thyroiditis influence
Calcific nodule may be wrongly assessed
Cystic nodule may be wrongly assessed
|
Quantitative USE
|
Non-invasive
No contrast medium
Safe
Same probe and US machine of B-mode evaluation
Defined in some guidelines
Not overly time-consuming
Good intra-observed agreement
Good inter-observed agreement
|
Univocal cut-off missing
Two different measurement units (m/s and kPa)
Soft carcinoma evaluation (thyroid follicular carcinoma)
Undefined thyroiditis influence
Calcific nodule may be wrongly assessed
Cystic nodule may be wrongly assessed
|
CEUS qualitative
|
|
Sulfur-based contrast medium use
Not approved in clinical practice by the guidelines (only approved for research)
Undefined intra-observed agreement
Undefined inter-observed agreement
More time-consuming than USE
|
CEUS quantitative (T/I curve)
|
|
Sulfur-based contrast medium use
Not approved in clinical practice by the guidelines (only approved for research)
Undefined intra-observed agreement
Undefined inter-observed agreement
More time-consuming than USE
|
US CAD System
|
Non-invasive
No contrast medium
Safe
Same probe and US machine of B-mode evaluation
Not overly time-consuming
Good intraobserved agreement
Good interobserved agreement
Improves the accuracy of inexperienced or non-specialist radiologists
|
|
Molecular test
|
|
Cost-effective only in carefully selected nodules
Variable performance according to the pre-test probability of malignancy
High costs (still unavailable/unaffordable in many countries)
|